Cas:898547-79-0 Methyl (3R,4S)-1-benzyl-4-(4-methylphenyl)-3-pyrrolidinecarboxyla te manufacturer & supplier

Chemical Name:Methyl (3R,4S)-1-benzyl-4-(4-methylphenyl)-3-pyrrolidinecarboxyla te

CAS.NO:898547-79-0

Synonyms:Trans-methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate

Molecular Formula:C₂₀H₂₃NO₂

Molecular Weight:309.40200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.54000

Exact Mass:309.17300

LogP:3.32150

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Trans-methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Trans-methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Trans-methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate Use and application,Trans-methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate technical grade,usp/ep/jp grade.

Related News: Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies. Methyl (3R,4S)-1-benzyl-4-(4-methylphenyl)-3-pyrrolidinecarboxyla te manufacturer At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. Methyl (3R,4S)-1-benzyl-4-(4-methylphenyl)-3-pyrrolidinecarboxyla te supplier At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. Methyl (3R,4S)-1-benzyl-4-(4-methylphenyl)-3-pyrrolidinecarboxyla te vendor At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up. Methyl (3R,4S)-1-benzyl-4-(4-methylphenyl)-3-pyrrolidinecarboxyla te factory Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.